TY - JOUR
T1 - Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained from Women and Men
AU - Kidd, Sarah
AU - Moore, Page C.
AU - Kirkcaldy, Robert D.
AU - Philip, Susan S.
AU - Wiesenfeld, Harold C.
AU - Papp, John R.
AU - Kerndt, Peter R.
AU - Venkatasubramanian, Lalitha
AU - Ghanem, Khalil G.
AU - Hook, Edward W.
N1 - Publisher Copyright:
© 2015 by the American Sexually Transmitted Diseases Association.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2015/8/25
Y1 - 2015/8/25
N2 - The US system forgonococcal antimicrobial susceptibilitysurveillancemonitorstrendsexclusivelyamongmenwithurethral infection, thepopulation from whom the yield of gonococcal culture is highest. Little is known about the susceptibility of female urogenital isolates, and it is unclear whether gonococcal susceptibility among men who report sex exclusively with women (MSW) is representative of susceptibility among women. Methods: Using isolates collected during a recent treatment trial in 5 US cities, we performed a secondary analysis to compare antimicrobial susceptibilities of Neisseria gonorrhoeae urogenital isolates obtained from women, MSW, and men who have sex with men (MSM). Pretreatment isolates were collected from trial participants; minimum inhibitory concentrations (MICs) were determined by agar dilution. Geometric mean MICs were adjusted for geographic location using general linear models. Results: Susceptibility data for urogenital isolates from 56 women, 252 MSW, and 170MSMwere studied. The adjusted geometric mean ceftriaxoneMIC was similar among women (0.0067 μg/mL; 95%confidence interval [CI], 0.0049-0.0092 μg/mL) and MSW (0.0060 μg/mL; 95% CI, 0.0053-0.0066 μg/mL). In contrast, the adjusted geometric mean ceftriaxoneMIC was higher amongMSM(0.0098 μg/mL; 95% CI, 0.0082-0.0119 μg/mL) than among MSW. This same pattern was observed for other antimicrobials, including cefixime and azithromycin Conclusions: Ceftriaxone, cefixime, and azithromycinMICswere higher among MSM than among MSW, but were similar among women and MSW. These findings suggest that gonococcal antimicrobial susceptibility surveillance based on urethral isolates from MSW may adequately represent susceptibility of urogenital N. gonorrhoeae in women.
AB - The US system forgonococcal antimicrobial susceptibilitysurveillancemonitorstrendsexclusivelyamongmenwithurethral infection, thepopulation from whom the yield of gonococcal culture is highest. Little is known about the susceptibility of female urogenital isolates, and it is unclear whether gonococcal susceptibility among men who report sex exclusively with women (MSW) is representative of susceptibility among women. Methods: Using isolates collected during a recent treatment trial in 5 US cities, we performed a secondary analysis to compare antimicrobial susceptibilities of Neisseria gonorrhoeae urogenital isolates obtained from women, MSW, and men who have sex with men (MSM). Pretreatment isolates were collected from trial participants; minimum inhibitory concentrations (MICs) were determined by agar dilution. Geometric mean MICs were adjusted for geographic location using general linear models. Results: Susceptibility data for urogenital isolates from 56 women, 252 MSW, and 170MSMwere studied. The adjusted geometric mean ceftriaxoneMIC was similar among women (0.0067 μg/mL; 95%confidence interval [CI], 0.0049-0.0092 μg/mL) and MSW (0.0060 μg/mL; 95% CI, 0.0053-0.0066 μg/mL). In contrast, the adjusted geometric mean ceftriaxoneMIC was higher amongMSM(0.0098 μg/mL; 95% CI, 0.0082-0.0119 μg/mL) than among MSW. This same pattern was observed for other antimicrobials, including cefixime and azithromycin Conclusions: Ceftriaxone, cefixime, and azithromycinMICswere higher among MSM than among MSW, but were similar among women and MSW. These findings suggest that gonococcal antimicrobial susceptibility surveillance based on urethral isolates from MSW may adequately represent susceptibility of urogenital N. gonorrhoeae in women.
UR - http://www.scopus.com/inward/record.url?scp=84937774479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937774479&partnerID=8YFLogxK
U2 - 10.1097/OLQ.0000000000000312
DO - 10.1097/OLQ.0000000000000312
M3 - Article
C2 - 26165435
AN - SCOPUS:84937774479
SN - 0148-5717
VL - 42
SP - 434
EP - 439
JO - Sexually transmitted diseases
JF - Sexually transmitted diseases
IS - 8
ER -